Skip to main content

Market Overview

G20 Countries Water Down US Push For COVID-19 IP Waiver: Reuters

G20 Countries Water Down US Push For COVID-19 IP Waiver: Reuters
  • G20, a global forum representing the world’s largest economies, has come forward supporting “voluntary licensing” of COVID-19 vaccine patents, the draft conclusions of a summit shows.
  • The leaders have stressed “voluntary licensing, technology and knowledge transfer, and patent-pooling” in their conclusion in a draft document seen by Reuters.
  • The draft, which is still subject to changes, results from a compromise among experts from G20 nations that remain divided over the waiving of intellectual property rights for COVID-19 vaccines.
  • Under a patent pool, drugmakers decide voluntarily to share licenses to manufacture their products in poorer nations.
  • As a step to boost manufacturing and ease supply constraints, the Biden administration came out in favor of a proposal to suspend intellectual property protections for shots. The news pressured shares of COVID-19 vaccine developers.

Related Articles (PFE + BNTX)

View Comments and Join the Discussion!

Posted-In: COVID-19 Vaccine ReutersBiotech Government News Health Care FDA General Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at